Jeavons syndrome
Jeavons syndrome is a rare genetic disorder characterized by the onset of photosensitive epilepsy in childhood. It is also known as eyelid myoclonia with absences (EMA).
Symptoms[edit]
The primary symptoms of Jeavons syndrome include eyelid myoclonia, absences, and photosensitivity. Eyelid myoclonia is a condition where the eyelids twitch or jerk uncontrollably. Absences are brief, sudden lapses of consciousness. Photosensitivity is an abnormal sensitivity to visual stimuli, such as flashing lights.
Causes[edit]
Jeavons syndrome is believed to be caused by a genetic mutation. However, the exact gene responsible has not yet been identified. It is thought to be inherited in an autosomal dominant manner, which means one copy of the altered gene in each cell is sufficient to cause the disorder.
Diagnosis[edit]
Diagnosis of Jeavons syndrome is based on the presence of the characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. These tests may include electroencephalogram (EEG), which measures the electrical activity of the brain.
Treatment[edit]
Treatment of Jeavons syndrome is aimed at managing the symptoms. This may include medications to control seizures and manage photosensitivity. In some cases, surgery may be necessary.
Prognosis[edit]
The prognosis for individuals with Jeavons syndrome varies. Some individuals may experience a decrease in symptoms over time, while others may continue to experience symptoms throughout their lives.
See also[edit]
References[edit]
External links[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
